These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 15356071)

  • 41. Lidocaine pharmacokinetics in postmenopausal women on hormone therapy.
    Gawronska-Szklarz B; Zarzycki M; Musial HD; Pudlo A; Loniewski I; Drozdzik M
    Menopause; 2006; 13(5):793-8. PubMed ID: 16894333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship between albuminuria and hormone therapy in postmenopausal women.
    Agarwal M; Selvan V; Freedman BI; Liu Y; Wagenknecht LE
    Am J Kidney Dis; 2005 Jun; 45(6):1019-25. PubMed ID: 15957130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rosiglitazone lowers blood pressure and increases arterial compliance in postmenopausal women with type 2 diabetes.
    Honisett SY; Stojanovska L; Sudhir K; Kingwell BA; Dawood T; Komesaroff PA
    Diabetes Care; 2003 Nov; 26(11):3194-5. PubMed ID: 14578270
    [No Abstract]   [Full Text] [Related]  

  • 44. Hormonal treatment increases the response of the reward system at the menopause transition: a counterbalanced randomized placebo-controlled fMRI study.
    Thomas J; Météreau E; Déchaud H; Pugeat M; Dreher JC
    Psychoneuroendocrinology; 2014 Dec; 50():167-80. PubMed ID: 25222702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of acute administration of natural progesterone on peripheral vascular responsiveness in healthy postmenopausal women.
    Mercuro G; Pitzalis L; Podda A; Zoncu S; Pilia I; Melis GB; Cherchi A
    Am J Cardiol; 1999 Jul; 84(2):214-8. PubMed ID: 10426343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Menopause, estrogens, and endothelial dysfunction: current concepts.
    Maturana MA; Irigoyen MC; Spritzer PM
    Clinics (Sao Paulo); 2007 Feb; 62(1):77-86. PubMed ID: 17334553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of hormone replacement therapy on plaque stability, inflammation, and fibrinolysis in hypertensive or overweight postmenopausal women.
    Koh KK; Ahn JY; Kang MH; Kim DS; Jin DK; Sohn MS; Park GS; Choi IS; Shin EK
    Am J Cardiol; 2001 Dec; 88(12):1423-6, A8. PubMed ID: 11741566
    [No Abstract]   [Full Text] [Related]  

  • 48. Plasma concentrations of vascular endothelial growth factor are associated with peripheral oedema in patients treated with thiazolidinedione.
    Emoto M; Fukuda N; Nakamori Y; Taguchi A; Okuya S; Oka Y; Tanizawa Y
    Diabetologia; 2006 Sep; 49(9):2217-8. PubMed ID: 16816953
    [No Abstract]   [Full Text] [Related]  

  • 49. Menopause and hormone therapy in the 21st century: why promote transdermal estradiol and progesterone?
    Scarabin PY; Canonico M; Plu-Bureau G; Oger E
    Heart; 2020 Aug; 106(16):1278. PubMed ID: 32444503
    [No Abstract]   [Full Text] [Related]  

  • 50. Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?
    Mauvais-Jarvis F
    Diabetes; 2017 Mar; 66(3):568-570. PubMed ID: 28223340
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical Impact of Blood Testosterone Concentration on Cardio-Ankle Vascular Index in Female Patients With Type 2 Diabetes Mellitus.
    Hitsumoto T
    Cardiol Res; 2019 Feb; 10(1):9-17. PubMed ID: 30834054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-Atherosclerotic Effects of a Phytoestrogen-Rich Herbal Preparation in Postmenopausal Women.
    Myasoedova VA; Kirichenko TV; Melnichenko AA; Orekhova VA; Ravani A; Poggio P; Sobenin IA; Bobryshev YV; Orekhov AN
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelial dysfunction in diabetes mellitus.
    Hadi HA; Suwaidi JA
    Vasc Health Risk Manag; 2007; 3(6):853-76. PubMed ID: 18200806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogen and hypertension.
    Ashraf MS; Vongpatanasin W
    Curr Hypertens Rep; 2006 Oct; 8(5):368-76. PubMed ID: 16965722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
    Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women.
    Gerhard M; Walsh BW; Tawakol A; Haley EA; Creager SJ; Seely EW; Ganz P; Creager MA
    Circulation; 1998 Sep; 98(12):1158-63. PubMed ID: 9743505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of rosiglitazone on the cardiovascular profile in postmenopausal women without diabetes mellitus: interplay of thiazolidinediones and hormone therapy.
    Chen IC; Lee WH; Chao TH; Li YH; Tsai WC; Pan HA; Tseng SY; Chen JY
    Menopause; 2012 Jul; 19(7):812-9. PubMed ID: 22415569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents.
    Dandona P; Aljada A
    J Diabetes Complications; 2004; 18(2):91-102. PubMed ID: 15120703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormone therapy impairs endothelial function in postmenopausal women with type 2 diabetes mellitus treated with rosiglitazone.
    Honisett SY; Stojanovska L; Sudhir K; Kingwell BA; Dawood T; Komesaroff PA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4615-9. PubMed ID: 15356071
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.